Darren R Veach - JoVE Visualize

Showing results (11-20 of 44) with videos related to

Pageof 5

Sort By:

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2010

(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivoMikhail Doubrovin, Tatiana Kochetkova, Elmer Santos, et al.

Bioorganic & Medicinal Chemistry Letters|November 6, 2009

Structure-activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: toward selective Abl inhibitorsChristophe Antczak, Darren R Veach, Christina N Ramirez, et al.

Blood|October 2, 2004

A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitorNikolas von Bubnoff, Darren R Veach, Heiko van der Kuip, et al.

Nuclear Medicine and Biology|May 10, 2005

Synthesis and in vitro examination of [124I]-, [125I]- and [131I]-2-(4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitorsDarren R Veach, Mohammad Namavari, Tatiana Beresten, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 11, 2026

Nonsteroidal 18F-Labeled PET Tracer for Imaging Androgen ReceptorsVilma I J Jallinoja, Joo Sun Mun, Alexandra Campanella, et al.

Cancer Research|August 3, 2002

Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinasesDavid Wisniewski, Caryl L Lambek, Chongyuan Liu, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2016

Remodeling the Vascular Microenvironment of Glioblastoma with α-ParticlesKatja Behling, William F Maguire, Valentina Di Gialleonardo, et al.

Journal of Medicinal Chemistry|October 25, 2007

Synthesis and biological evaluation of a fluorine-18 derivative of dasatinibDarren R Veach, Mohammad Namavari, Nagavarakishore Pillarsetty, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 2, 2012

Imatinib resistance and microcytic erythrocytosis in a KitV558Δ;T669I/+ gatekeeper-mutant mouse model of gastrointestinal stromal tumorBenedikt Bosbach, Shayu Deshpande, Ferdinand Rossi, et al.

Neoplasia (New York, N.Y.)|January 12, 2013

Fluorine-labeled dasatinib nanoformulations as targeted molecular imaging probes in a PDGFB-driven murine glioblastoma modelMiriam Benezra, Dolores Hambardzumyan, Oula Penate-Medina, et al.

Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:

Pageof 5

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2010

(124)I-iodopyridopyrimidinone for PET of Abl kinase-expressing tumors in vivoMikhail Doubrovin, Tatiana Kochetkova, Elmer Santos, et al.

Bioorganic & Medicinal Chemistry Letters|November 6, 2009

Structure-activity relationships of 6-(2,6-dichlorophenyl)-8-methyl-2-(phenylamino)pyrido[2,3-d]pyrimidin-7-ones: toward selective Abl inhibitorsChristophe Antczak, Darren R Veach, Christina N Ramirez, et al.

Blood|October 2, 2004

A cell-based screen for resistance of Bcr-Abl-positive leukemia identifies the mutation pattern for PD166326, an alternative Abl kinase inhibitorNikolas von Bubnoff, Darren R Veach, Heiko van der Kuip, et al.

Nuclear Medicine and Biology|May 10, 2005

Synthesis and in vitro examination of [124I]-, [125I]- and [131I]-2-(4-iodophenylamino) pyrido[2,3-d]pyrimidin-7-one radiolabeled Abl kinase inhibitorsDarren R Veach, Mohammad Namavari, Tatiana Beresten, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 11, 2026

Nonsteroidal 18F-Labeled PET Tracer for Imaging Androgen ReceptorsVilma I J Jallinoja, Joo Sun Mun, Alexandra Campanella, et al.

Cancer Research|August 3, 2002

Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinasesDavid Wisniewski, Caryl L Lambek, Chongyuan Liu, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 5, 2016

Remodeling the Vascular Microenvironment of Glioblastoma with α-ParticlesKatja Behling, William F Maguire, Valentina Di Gialleonardo, et al.

Journal of Medicinal Chemistry|October 25, 2007

Synthesis and biological evaluation of a fluorine-18 derivative of dasatinibDarren R Veach, Mohammad Namavari, Nagavarakishore Pillarsetty, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 2, 2012

Imatinib resistance and microcytic erythrocytosis in a KitV558Δ;T669I/+ gatekeeper-mutant mouse model of gastrointestinal stromal tumorBenedikt Bosbach, Shayu Deshpande, Ferdinand Rossi, et al.

Neoplasia (New York, N.Y.)|January 12, 2013

Fluorine-labeled dasatinib nanoformulations as targeted molecular imaging probes in a PDGFB-driven murine glioblastoma modelMiriam Benezra, Dolores Hambardzumyan, Oula Penate-Medina, et al.

Pageof 5